Mortality associated with irinotecan plus bolus fluorouracil/leucovorin.
Bleiberg
Harry
H
Di Leo
Angelo
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002166:Camptothecin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000401:mortality; D015179:Colorectal Neoplasms / Q000188:drug therapy; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D000077146:Irinotecan; D002955:Leucovorin / Q000008:administration & dosage / Q000009:adverse effects; D013577:Syndrome; D013927:Thrombosis / Q000139:chemically induced* / Q000401:mortality
D000077146:Irinotecan; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin